Hyku Biosciences raised a total of $64M in seed financing led by Chugai Venture Fund to advance its proprietary platform for developing precision medicines.
Amount Raised
$64 Million
Round Type
Seed
LexingtonBiotechnologyHealth CareTherapeuticsInvestors
Description
Hyku Biosciences Inc. appointed John Gustofson to its Board of Directors alongside a significant investment from Chugai Venture Fund. This investment brings the company's total seed financing to $64M, supporting its efforts in developing innovative precision medicines.
Quick answer
Hyku Biosciences raised $64 Million in a Seed round, dated November 12, 2024. Investors: Eisai Innovation, Chugai Venture Fund, RA Capital Management, Novartis Venture Fund, Droia Ventures, The Mark Foundation For Cancer Research and KB Investment. Hyku Biosciences is based in Lexington, Massachusetts, United States.
- How much did Hyku Biosciences raise?
- Hyku Biosciences raised $64 Million in a Seed round on November 12, 2024.
- Who invested in Hyku Biosciences?
- Eisai Innovation, Chugai Venture Fund, RA Capital Management, Novartis Venture Fund, Droia Ventures, The Mark Foundation For Cancer Research and KB Investment are named as investors in this round.
- What does Hyku Biosciences do?
- Hyku is a biotechnology company based in the greater Boston area, utilizing its proprietary discovery platform to inhibit disease targets that are challenging to address with conventional approaches.
- Where is Hyku Biosciences based and how big is it?
- Hyku Biosciences is based in Lexington, Massachusetts, United States. Fundz records about 16 employees.
- Who are the decision-makers at Hyku Biosciences?
- Fundz holds 2 contacts at Hyku Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Hyku Biosciences that raised within 45 days of this round, from Fundz verified event records.
- AusperBio raised $73M (Series B) on December 27, 2024.
- Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
- GEMMABio raised $34M (Series A) on December 23, 2024.
- Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
- Phio Pharmaceuticals raised $55K (Seed) on December 20, 2024.
- Borealis Biosciences raised $30M (Series A) on December 19, 2024.
Who to call at Hyku Biosciences, and when
A new round usually means Hyku Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Hyku Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Hyku Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Hyku Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Hyku Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Hyku Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.